These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15864380)

  • 1. Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype.
    Lopez-Beltran A; Qian J; Montironi R; Luque RJ; Bostwick DG
    Int J Surg Pathol; 2005 Apr; 13(2):167-73. PubMed ID: 15864380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear volume estimates in prostatic atypical adenomatous hyperplasia.
    López-Beltrán A; Artacho-Pérula E; Luque-Barona RJ; Roldán-Villalobos R
    Anal Quant Cytol Histol; 2000 Dec; 22(6):438-44. PubMed ID: 11147297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies.
    Bostwick DG; Qian J
    Am J Surg Pathol; 1995 May; 19(5):506-18. PubMed ID: 7537024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.
    Qian J; Bostwick DG
    Pathol Res Pract; 1995 Sep; 191(9):860-7. PubMed ID: 8606866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
    Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
    Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is atypical adenomatous hyperplasia of the prostate a precursor lesion?
    Zhang C; Montironi R; MacLennan GT; Lopez-Beltran A; Li Y; Tan PH; Wang M; Zhang S; Iczkowski KA; Cheng L
    Prostate; 2011 Dec; 71(16):1746-51. PubMed ID: 21480308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?
    Cheng L; Shan A; Cheville JC; Qian J; Bostwick DG
    Cancer Res; 1998 Feb; 58(3):389-91. PubMed ID: 9458077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma.
    Bostwick DG; Srigley J; Grignon D; Maksem J; Humphrey P; van der Kwast TH; Bose D; Harrison J; Young RH
    Hum Pathol; 1993 Aug; 24(8):819-32. PubMed ID: 8375853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
    Helpap B; Bonkhoff H; Cockett A; Montironi R; Troncoso P; Waters D; Bostwick D
    Pathologica; 1997 Jun; 89(3):288-300. PubMed ID: 9270265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate.
    Yang XJ; Wu CL; Woda BA; Dresser K; Tretiakova M; Fanger GR; Jiang Z
    Am J Surg Pathol; 2002 Jul; 26(7):921-5. PubMed ID: 12131160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
    Helpap B; Riede C
    Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical adenomatous hyperplasia of the prostate: a critical review.
    Grignon DJ; Sakr WA
    Eur Urol; 1996; 30(2):206-11. PubMed ID: 8875202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin A and Ki-67 with DNA content in benign and malignant prostatic epithelial lesions.
    Mirtti T; Kallajoki M; Aaltonen M; Alanen K
    Anal Quant Cytol Histol; 2001 Jun; 23(3):229-37. PubMed ID: 11444193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate.
    Helpap B
    Pathol Res Pract; 1995 Sep; 191(9):904-7. PubMed ID: 8606872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.
    Stamatiou K; Alevizos A; Natzar M; Mihas C; Mariolis A; Michalodimitrakis E; Sofras F
    Asian J Androl; 2007 Mar; 9(2):229-33. PubMed ID: 16751999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Urology; 1995 Dec; 46(6):837-42. PubMed ID: 7502426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
    Bostwick DG
    Cancer; 1996 Jul; 78(2):330-6. PubMed ID: 8674012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical evaluation of TMPRSS2-ERG gene fusion in adenosis of the prostate.
    Green WM; Hicks JL; De Marzo A; Illei PP; Epstein JI
    Hum Pathol; 2013 Sep; 44(9):1895-901. PubMed ID: 23664537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.